Eradication of Helicobacter pylori Does Not Reduce the Incidence of Gastroduodenal Ulcers in Patients on Long-term NSAID Treatment: Double-Blind, Randomized, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Eradication of Helicobacter pylori Does Not Reduce the Incidence of Gastroduodenal Ulcers in Patients on Long-term NSAID Treatment: Double-Blind, Randomized, Placebo-Controlled Trial

Published:2007-10 Issue:5 Volume:12 Page:477-485
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

de Leest Helena T.J.I.,Steen Kirsti S.S.,Lems Willem F.,Bijlsma Johannes W.J.,van de Laar Mart A.F.J.,Huisman A. Margriet,Vonkeman Harald E.,Houben Harry H.M.L.,Kadir Sylvana W.,Kostense Piet J.,van Tulder Maurits W.,Kuipers Ernst J.,Boers Maarten,Dijkmans Ben A.C.

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1523-5378.2007.00543.x/fullpdf

Reference38 articles.

1. Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs

2. Nonsteroidal anti-inflammatory drug gastropathy

3. Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis

4. Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS);Zeitschrift für Gastroenterologie;2024-02

2. Úlcera péptica;Medicina Clínica;2023-09

3. Peptic ulcer;Medicina Clínica (English Edition);2023-09

4. Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001;Zeitschrift für Gastroenterologie;2023-05

5. Gastrointestinal and cardiovascular adverse events associated with NSAIDs;Expert Opinion on Drug Safety;2021-08-18